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Vascular access for dialysis continues to be a
major health problem for patients with end-stage
renal failure; it is the main reason they are admitted
to the hospital and results in most of the morbidities
they have. It is also a problem for vascular surgeons
as they continue to watch their technically perfect
anastomoses fail over a short period of time as a
result of a process we still do not fully understand.
Diminishing health care dollars are continuously
spent on these access grafts to maintain graft paten-
cy for the preservation of life.
It is not disputable that autologous arteriovenous
fistulas are the procedure of choice for any patient with
end-stage renal failure because of the fistulas’ superb
patency and virtual zero infection rate. However, not
all patients are candidates anatomically for these proce-
dures, especially women, elderly patients, and patients
with diabetes. Therefore, the search for a method to
improve the patency of the prosthetic graft continues.
This excellent group of vascular access surgeons
from the Norfolk Surgical Group and the Naval
Medical Center at Portsmouth attempted the place-
ment of a Tyrell vein collar in a prospective manner
in patients who required a prosthetic dialysis access
graft. Their expectations were that the proposed
mechanism of the vein patch in arterial bypass grafts
of decreased compliance mismatch and distortion
would also decrease the proliferation on intimal
hyperplasia at the venous anastomosis. The studies
showed exactly the opposite, and the authors appro-
priately stopped their trial prematurely. Therefore,
only 17 patients were randomized: 10 patients were
in a control group, and seven patients received a
Tyrell patch. The assumption that the different
hemodynamic stresses seen in vascular access grafts
are responsible is undoubtedly true; the mechanism
is unclear. Continuous damage to the venous
endothelium is also probably taking place with the
creation of an arteriovenous graft and can contribute
to a state of active vessel wall remodeling.
The second study published reports the results of
a prospective, randomized multicenter trial in the
Netherlands. Six hospitals participated. A total of
120 patients were enrolled in this study: 61 patients
had no cuffs, and 59 patients had cuffs. Follow-up
was quite complete with duplex scanning and
angiograms being performed in all patients at 3
months. Even though the incidence of thrombotic
occlusion was lower in those patients with a venous
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cuff, primary and secondary patency rates were com-
parable between the two groups. The cuff group
also had less stenosis as shown with duplex scan and
angiogram. Poorer patency rates in their series were
associated with small vein diameter (< 4 mm) and
local problems such as obesity, local edema, and skin
atrophy that led to wound problems.
These two studies provide clinical information
that reveals that all intimal hyperplasia is not the
same: intimal hyperplasia occurring solely in an arte-
rial anastomosis is different than that occurring sole-
ly in a venous anastomosis. Certainly, as shown in
these two studies, an arteriovenous anastomosis
develops a different type of anastomotic intimal
hyperplasia. The high turbulent flow results in alter-
ations of sheer stress and vessel wall interactions with
bloodborne elements such as red blood cells, white
blood cells, and platelets. Active damage that
requires remodeling of the vessel possibly contributes
to the accelerated venous outflow lesion of intimal
hyperplasia in this setting. It is a lesion that is affect-
ed each day because of the high-flow dynamics.1,2
The arterial injury that occurs when a prosthetic
graft is placed involves the body’s reaction to the
foreign substance with the subsequent activation of
macrophages. These macrophages can then release
chemotactic factors such as platelet-derived growth
factor, transforming growth factor–β, and, perhaps,
angiotensin II.3,4 These factors result in the migra-
tion of endothelial cells as well as smooth muscle
cells. It is known then that these endothelial cells are
dysfunctional and no longer produce their normal
inhibitory products, such as nitric oxide, that help to
maintain the proper physiology of the vessel wall.
The smooth muscle cells proliferate, migrate, and
become entrenched in the overproduction of extra-
cellular matrix. All of these smooth muscle cell reac-
tions lead to the production of the intimal hyper-
plastic lesion.
Shear stress has also been shown to augment the
intimal hyperplastic response after placement of a pros-
thetic graft. Shear stress is directly related to the mean
velocity through the graft and increases exponentially
as the outflow narrows because of intimal hyperplasia.5
The velocity that is created through an arteriovenous
graft is much higher than that in an arterial bypass
graft. Therefore, the fact that an increased amount of
intimal hyperplasia is seen at the venous anastomosis is
not surprising. Shear stress causes smooth muscle cells
to proliferate and also causes the production of extra-
cellular matrix. 
The only effect that the addition of a vein patch
could have had on the configuration of these pros-
thetic arteriovenous grafts was to add a larger diam-
eter to accommodate the intimal hyperplasia longer
before it became flow limiting. Veins exposed to
arterial flow also lose their endothelial cell function.
The increased wall tension and mechanical trauma
also lead to smooth muscle cell proliferation, migra-
tion, and extracellular matrix production. The argu-
ment has been that in the arterial bypass graft circuit,
these vein patches may increase compliance at the
anastomosis, which could lead to decreased shear
stress. However, in the dialysis graft, the high veloc-
ity and flow of the blood make correction of com-
pliance impossible. 
In the future, we may need to rely on the
improvement of the actual dialysis machines, which
would make the process much more efficient.
Perhaps, this would require less flow through these
grafts, which might decrease the severity of the
occurrence of intimal hyperplasia. Many researchers
are still investigating the pharmacologic alteration of
intimal hyperplasia, but no one single agent is avail-
able that can correct the problem. Currently, we are
involved in using laser photodynamic therapy at the
venous site in a dog model of an arteriovenous pros-
thetic graft to determine if we can limit the amount
of intimal hyperplasia that occurs and causes graft
failure. This perhaps could be applied during the
lifetime of the graft and could allow the grafts to
function for longer periods of time with a bit of laser
sculpting of the venous anastomotic end point. 
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